Home » Ception, Cephalon Provide Initial Results of Cinquil Trial
Ception, Cephalon Provide Initial Results of Cinquil Trial
Ception Therapeutics, Inc., a privately held biopharmaceutical company, and
Cephalon, Inc. announced results from a Phase IIb/III clinical trial for CINQUIL (reslizumab) as a treatment for pediatric eosinophilic esophagitis.
San Francisco Business Times
San Francisco Business Times
Upcoming Events
-
02May
-
07May
-
14May
-
23May
-
30May